» Articles » PMID: 35397067

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumours of the Ear

Overview
Specialties Oncology
Pathology
Date 2022 Apr 9
PMID 35397067
Authors
Affiliations
Soon will be listed here.
Abstract

In the recently published 5th Edition of the World Health Organisation Classification of Head and Neck Tumours, there are relatively few changes to report in terms of nomenclature in lesions of ear and temporal bone and fewer developments in molecular pathogenesis in comparison to other sites, particularly in sinonasal tract. Ear and temporal bone tumours are rare and biopsy material is limited. As a result, resources in the literature are scarce with few large series, no controlled clinical trials and the approaches to staging and management are not standardised. New entities are difficult to characterise. The number of entries has, however, increased for tumours of the ear and temporal bone (thirteen) compared to the 4th Edition (eleven). Some lesions previously included in the 4th Edition considered to have no site-specific features have been excluded to be discussed elsewhere and other benign lesions that are specific to this site have been included. The tumours and tumour-like entities of ear and temporal bone are discussed here mindful that the chapter in the 5th edition better correlates disease processes with clinical information and imaging and as far as possible standardises nomenclature.

Citing Articles

ETV6::NTRK3-associated papillary adenocarcinoma: let us play it by ear.

Bell D, Maghami E, Bakkar R, Afkhami M Virchows Arch. 2024; 485(6):1161-1165.

PMID: 38206384 DOI: 10.1007/s00428-024-03735-6.


Malignant tumors of the external auditory canal: diagnosis, treatment, genetic landscape, biomarkers, and clinical outcome.

Samara P, Athanasopoulos M, Goulioumis A, Athanasopoulos I Explor Target Antitumor Ther. 2023; 4(5):801-811.

PMID: 37970205 PMC: 10645464. DOI: 10.37349/etat.2023.00169.


Middle Ear Neuroendocrine Tumor Mimicking As Chronic Otitis Media.

Sukumaran Y, Ong Y, Ping L, Ong C, Narayanan P Cureus. 2023; 15(7):e42296.

PMID: 37609079 PMC: 10441585. DOI: 10.7759/cureus.42296.


Pleomorphic adenoma of the external auditory canal.

Aradhya S, Ravishankar N, Satish S Autops Case Rep. 2023; 13:e2023428.

PMID: 37101554 PMC: 10124559. DOI: 10.4322/acr.2023.428.


Immunohistochemical Expression Pattern of Theragnostic Targets SSTR2 and PSMA in Endolymphatic Sac Tumors: A Single Institution Case Series.

Brada M, Rushing E, Bachinger D, Zoller L, Burger I, Hullner M Head Neck Pathol. 2022; 16(4):1012-1018.

PMID: 35546652 PMC: 9729512. DOI: 10.1007/s12105-022-01456-3.

References
1.
Jacoby L, Maccollin M, Barone R, Ramesh V, Gusella J . Frequency and distribution of NF2 mutations in schwannomas. Genes Chromosomes Cancer. 1996; 17(1):45-55. DOI: 10.1002/(SICI)1098-2264(199609)17:1<45::AID-GCC7>3.0.CO;2-2. View

2.
Bachir S, Shah S, Shapiro S, Koehler A, Mahammedi A, Samy R . Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis. Int J Mol Sci. 2021; 22(2). PMC: 7828193. DOI: 10.3390/ijms22020690. View

3.
Zhang J, Tingting H, Jin Y, Xianmin W, Li H, Xiaoyun C . A Rare Case of Adenoid Cystic Carcinoma Isolated in the Mastoid. J Int Adv Otol. 2019; 15(1):177-180. PMC: 6483448. DOI: 10.5152/iao.2019.6036. View

4.
Xu B, Chetty R, Perez-Ordonez B . Neuroendocrine neoplasms of the head and neck: some suggestions for the new WHO classification of head and neck tumors. Head Neck Pathol. 2014; 8(1):24-32. PMC: 3950384. DOI: 10.1007/s12105-014-0531-y. View

5.
Declau F, Spaendonck M, Timmermans J, Michaels L, Liang J, Qiu J . Prevalence of otosclerosis in an unselected series of temporal bones. Otol Neurotol. 2001; 22(5):596-602. DOI: 10.1097/00129492-200109000-00006. View